FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145305890> ?p ?o ?g. }

• W2145305890 endingPage "R44" @default.
• W2145305890 startingPage "R44" @default.
• W2145305890 abstract "Rheumatoid synovial fibroblasts (RASFs) mediate joint inflammation and destruction in rheumatoid arthritis (RA). Endothelial protein C receptor (EPCR) is a specific receptor for the natural anticoagulant activated protein C (APC). It mediates the cytoprotective properties of APC and is expressed in rheumatoid synovial tissue. A recent report shows that group V secretory phospholipase A2 (sPLA2V) prevents APC from binding to EPCR in endothelium and inhibits EPCR/APC function. The aim of this study was to investigate the expression and function of EPCR on RASFs. Human synovial fibroblasts (SFs) were isolated from RA or osteoarthritis (OA) synovial tissues and treated with control, EPCR, or sPLA2V small interfering RNA (siRNA); recombinant human APC, tumor necrosis factor-alpha (TNF-α), or sPLA2V. RASF viability and migration/invasion were measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and collagen gel migration/invasion assays, respectively, and cartilage degradation by 1,9-dimethylmethylene blue (DMMB) assay in the presence of human OA articular cartilage explants. The expression or activation of cytokines, EPCR, cadherin-11, mitogen-activated protein (MAP) kinases, and nuclear factor-kappa-B (NF-κB) or both were detected by enzyme-linked immunosorbent assay, Western blotting, or immunostaining. EPCR was expressed by both OASFs and RASFs but was markedly increased in RASFs. When EPCR was suppressed by siRNA or blocking antibody cell viability, cell invasion and cartilage degradation were reduced by more than 30%. Inflammatory mediators interleukin-1-beta (IL-1β), cadherin-11, and NF-κB were significantly reduced by EPCR suppression under control or TNF-α-stimulated conditions. The expression or activation (or both) of MAP kinases ERK, p38, and JNK were also markedly decreased in cells transfected with EPCR siRNA. Further analysis revealed that sPLA2V co-localized with EPCR on RASFs. Suppression of sPLA2V reduced cell viability and cartilage degradation and increased APC binding to RASFs. Conversely, recombinant sPLA2V increased cartilage degradation, blocked APC binding to RASFs, and could not rescue the effects induced by EPCR suppression. Our results demonstrate that EPCR is overexpressed by RASFs and mediates the aggressive behavior of RASFs. This function of EPCR is contrary to its cytoprotective role in other settings and is likely driven by sPLA2V." @default.
• W2145305890 created "2016-06-24" @default.
• W2145305890 creator A5006228270 @default.
• W2145305890 creator A5011312213 @default.
• W2145305890 creator A5012482161 @default.
• W2145305890 creator A5012952846 @default.
• W2145305890 creator A5023553044 @default.
• W2145305890 creator A5031606706 @default.
• W2145305890 creator A5057623896 @default.
• W2145305890 creator A5064711465 @default.
• W2145305890 creator A5081322009 @default.
• W2145305890 date "2014-01-01" @default.
• W2145305890 modified "2023-10-16" @default.
• W2145305890 title "Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2" @default.
• W2145305890 cites W1577692113 @default.
• W2145305890 cites W1964415576 @default.
• W2145305890 cites W1966083155 @default.
• W2145305890 cites W1969012694 @default.
• W2145305890 cites W1974680615 @default.
• W2145305890 cites W1975066637 @default.
• W2145305890 cites W1987640476 @default.
• W2145305890 cites W1990687029 @default.
• W2145305890 cites W1997131908 @default.
• W2145305890 cites W1999929677 @default.
• W2145305890 cites W2003472447 @default.
• W2145305890 cites W2003748778 @default.
• W2145305890 cites W2016261481 @default.
• W2145305890 cites W2025851689 @default.
• W2145305890 cites W2032255522 @default.
• W2145305890 cites W2041148365 @default.
• W2145305890 cites W2047217935 @default.
• W2145305890 cites W2048729530 @default.
• W2145305890 cites W2050633484 @default.
• W2145305890 cites W2050804496 @default.
• W2145305890 cites W2052733114 @default.
• W2145305890 cites W2070044720 @default.
• W2145305890 cites W2077965112 @default.
• W2145305890 cites W2078104401 @default.
• W2145305890 cites W2088625991 @default.
• W2145305890 cites W2110805002 @default.
• W2145305890 cites W2115390058 @default.
• W2145305890 cites W2117673199 @default.
• W2145305890 cites W2127366888 @default.
• W2145305890 cites W2135552434 @default.
• W2145305890 cites W2152348310 @default.
• W2145305890 doi "https://doi.org/10.1186/ar4473" @default.
• W2145305890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3979138" @default.
• W2145305890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24495480" @default.
• W2145305890 hasPublicationYear "2014" @default.
• W2145305890 type Work @default.
• W2145305890 sameAs 2145305890 @default.
• W2145305890 citedByCount "11" @default.
• W2145305890 countsByYear W21453058902015 @default.
• W2145305890 countsByYear W21453058902016 @default.
• W2145305890 countsByYear W21453058902019 @default.
• W2145305890 countsByYear W21453058902020 @default.
• W2145305890 countsByYear W21453058902022 @default.
• W2145305890 countsByYear W21453058902023 @default.
• W2145305890 crossrefType "journal-article" @default.
• W2145305890 hasAuthorship W2145305890A5006228270 @default.
• W2145305890 hasAuthorship W2145305890A5011312213 @default.
• W2145305890 hasAuthorship W2145305890A5012482161 @default.
• W2145305890 hasAuthorship W2145305890A5012952846 @default.
• W2145305890 hasAuthorship W2145305890A5023553044 @default.
• W2145305890 hasAuthorship W2145305890A5031606706 @default.
• W2145305890 hasAuthorship W2145305890A5057623896 @default.
• W2145305890 hasAuthorship W2145305890A5064711465 @default.
• W2145305890 hasAuthorship W2145305890A5081322009 @default.
• W2145305890 hasBestOaLocation W21453058901 @default.
• W2145305890 hasConcept C104317684 @default.
• W2145305890 hasConcept C105702510 @default.
• W2145305890 hasConcept C142724271 @default.
• W2145305890 hasConcept C153911025 @default.
• W2145305890 hasConcept C17991360 @default.
• W2145305890 hasConcept C185592680 @default.
• W2145305890 hasConcept C203014093 @default.
• W2145305890 hasConcept C204787440 @default.
• W2145305890 hasConcept C22615655 @default.
• W2145305890 hasConcept C2776164576 @default.
• W2145305890 hasConcept C2776268809 @default.
• W2145305890 hasConcept C2776816377 @default.
• W2145305890 hasConcept C2776914184 @default.
• W2145305890 hasConcept C2777292125 @default.
• W2145305890 hasConcept C2777652487 @default.
• W2145305890 hasConcept C2780550940 @default.
• W2145305890 hasConcept C54009773 @default.
• W2145305890 hasConcept C55493867 @default.
• W2145305890 hasConcept C71924100 @default.
• W2145305890 hasConcept C86803240 @default.
• W2145305890 hasConcept C89560881 @default.
• W2145305890 hasConceptScore W2145305890C104317684 @default.
• W2145305890 hasConceptScore W2145305890C105702510 @default.
• W2145305890 hasConceptScore W2145305890C142724271 @default.
• W2145305890 hasConceptScore W2145305890C153911025 @default.
• W2145305890 hasConceptScore W2145305890C17991360 @default.
• W2145305890 hasConceptScore W2145305890C185592680 @default.
• W2145305890 hasConceptScore W2145305890C203014093 @default.
• W2145305890 hasConceptScore W2145305890C204787440 @default.

• next